An estimated 30 million Americans have sleep apnea, yet a large share of moderate-to-severe cases remain undiagnosed, according to the American Academy of Sleep Medicine. Sleep apnea is a condition in which breathing repeatedly stops and starts during sleep, fragmenting rest and depriving the body of oxygen dozens or even hundreds of times per night. Far from being just a snoring problem, untreated sleep apnea is linked to hypertension, heart disease, atrial fibrillation, stroke, diabetes, depression, and motor-vehicle accidents. The good news is that effective treatments exist – once the condition is actually identified. This guide covers the types, health consequences, diagnosis, and full range of treatment options, including newer approaches. For related conditions, see our medical conditions guide. It is educational only and is not a substitute for advice from a qualified clinician.
The short version: Sleep apnea is repeated pauses in breathing during sleep. The most common type, obstructive sleep apnea (OSA), happens when the airway collapses; central sleep apnea is a problem with the brain’s breathing signals. Classic clues are loud snoring, a bed partner noticing you stop breathing or gasp, and being exhausted during the day. Untreated OSA meaningfully raises cardiovascular risk. Diagnosis is a sleep study (in-lab or a home test), and CPAP is the first-line treatment, with oral appliances, hypoglossal-nerve stimulation (Inspire), weight loss, and – as of a 2024 FDA approval – the medication tirzepatide (Zepbound) for moderate-to-severe OSA with obesity. If daytime sleepiness is bad enough to make driving dangerous, do not drive; and treat any signs of a heart attack or stroke as a 911 emergency. This article is educational and is not personal medical advice.
Some sleep-apnea situations are urgent. Seek prompt or emergency care if you notice any of the following:
- Severe daytime sleepiness that puts you at risk of drowsy driving – if you are fighting to stay awake at the wheel or have “microsleeps,” stop driving and arrange another way to get around until you are evaluated and treated. Drowsy driving causes crashes.
- Signs of a possible heart attack – chest pain or pressure, pain spreading to the arm or jaw, shortness of breath, or a cold sweat – call 911.
- Signs of a possible stroke – face drooping, arm weakness, or slurred speech (think “BE-FAST”) – call 911. See our stroke guide.
- Waking repeatedly gasping or choking, with new swelling in the legs or worsening breathlessness lying flat – get medical evaluation promptly, as this can signal heart or lung problems.
Types of Sleep Apnea
Obstructive Sleep Apnea (OSA)
Obstructive sleep apnea is by far the most common form, accounting for the large majority of cases. It occurs when the muscles in the back of the throat relax excessively during sleep, causing the soft tissues – including the tongue, soft palate, and pharyngeal walls – to collapse and block the airway. The brain senses the drop in oxygen and briefly arouses the sleeper to reopen the airway, usually without full awakening. This cycle can repeat from a handful to more than 100 times per hour throughout the night.
Central Sleep Apnea (CSA)
Central sleep apnea is less common and involves a failure of the brain to send the proper signals to the muscles that control breathing. Unlike OSA, there is no physical obstruction – the airway is open, but the respiratory effort simply stops. CSA is often associated with heart failure, stroke, opioid use, and high-altitude exposure. Cheyne-Stokes respiration, a distinctive crescendo-decrescendo breathing pattern seen in heart failure, is a form of CSA.
Complex (Treatment-Emergent) Sleep Apnea
Some patients initially diagnosed with OSA develop central apneas when treated with CPAP therapy, a phenomenon known as complex or treatment-emergent central sleep apnea. This occurs in a minority of OSA patients starting CPAP and often resolves over time, though some patients require adaptive servo-ventilation (ASV) or other specialized treatments.
Symptoms and Signs
The hallmark symptoms of sleep apnea include loud, chronic snoring (especially with gasping, choking, or snorting sounds), witnessed breathing pauses during sleep (reported by a bed partner), and excessive daytime sleepiness despite seemingly adequate hours in bed. Morning headaches, dry mouth upon waking, difficulty concentrating, irritability, and mood changes are also common.
Many patients do not recognize their own symptoms. Snoring is normalized, daytime sleepiness is attributed to busy schedules, and cognitive difficulties are blamed on aging. Bed partners are often the first to notice the alarming pattern of snoring punctuated by silence (apnea) followed by a gasping resumption of breathing. The Epworth Sleepiness Scale, a simple questionnaire that scores the likelihood of dozing off in various situations, can help quantify daytime sleepiness, and screening tools like STOP-Bang help clinicians estimate risk.
In women, the presentation may differ from the “classic” picture. Women with sleep apnea are more likely to report insomnia, morning headaches, mood disturbances, and fatigue rather than the dramatic snoring and witnessed apneas more commonly reported by men. This difference in presentation may contribute to the significant underdiagnosis of sleep apnea in women. According to the NHLBI, recognizing atypical presentations is essential for closing the diagnostic gap.
Risk Factors
Excess weight is the strongest risk factor for obstructive sleep apnea. Fat deposits around the upper airway narrow the breathing passage, and excess weight in the abdomen pushes against the diaphragm, reducing lung volume. Most OSA patients are overweight or have obesity, and weight gain is associated with a substantially higher risk of OSA. However, sleep apnea also occurs in lean individuals, particularly those with anatomical predispositions.
Anatomical factors that narrow the upper airway include a large neck circumference (roughly greater than 17 inches in men or 16 inches in women), large tonsils or adenoids, a recessed chin (retrognathia), a deviated septum, and nasal congestion. Craniofacial structure explains why sleep apnea is relatively common in certain populations – for example, some East Asian populations have higher rates of OSA at lower BMIs compared with Western populations due to differences in facial bone structure.
Age is a risk factor, with prevalence increasing through middle age and plateauing around age 65. Men are more likely to have OSA than premenopausal women, though the gap narrows substantially after menopause. Family history, smoking, alcohol use (which relaxes airway muscles), and use of sedating medications also increase risk. Conditions like prediabetes, hypothyroidism, and polycystic ovary syndrome are associated with higher sleep apnea prevalence.
Health Consequences of Untreated Sleep Apnea
The intermittent hypoxia (oxygen drops) and sleep fragmentation caused by untreated sleep apnea trigger a cascade of physiological consequences. The sympathetic nervous system is chronically activated, blood pressure rises, systemic inflammation increases, and metabolic dysfunction develops. The result is a significantly elevated risk of cardiovascular disease.
The American Heart Association recognizes untreated OSA as an independent risk factor for hypertension, coronary artery disease, heart failure, atrial fibrillation, and stroke. The relationship with hypertension is particularly strong – a large share of people with hard-to-control (resistant) high blood pressure have underlying OSA, and untreated OSA is a leading contributor to blood pressure that stays high despite multiple medications.
Metabolic effects include insulin resistance and increased risk of type 2 diabetes, independent of obesity. The repeated oxygen desaturations promote oxidative stress and inflammatory cytokine release, which impair glucose metabolism. Untreated sleep apnea also increases the risk of motor-vehicle accidents due to impaired alertness and reaction time – one reason drowsy driving is dangerous and why some commercial-driving rules address sleep apnea. Depression, cognitive decline, and reduced quality of life complete the picture of a disease with far-reaching systemic effects.
Diagnosis: The Sleep Study
The reference-standard diagnostic test for sleep apnea is polysomnography (PSG) – an overnight sleep study conducted in a sleep laboratory. PSG monitors brain activity (EEG), eye movements, muscle activity, heart rhythm, breathing effort, airflow, and oxygen saturation simultaneously. It identifies the type of sleep apnea (obstructive, central, or complex), determines severity, and documents other sleep disorders such as periodic limb movement disorder.
The severity of sleep apnea is expressed as the apnea-hypopnea index (AHI) – the number of apneas (complete breathing cessation for at least 10 seconds) and hypopneas (partial airflow reduction with oxygen desaturation or arousal) per hour of sleep. An AHI of 5-14 is classified as mild, 15-29 as moderate, and 30 or above as severe. The oxygen desaturation index (ODI) and the lowest oxygen saturation reached provide additional severity data.
Home sleep apnea testing (HSAT) has become an increasingly accepted and convenient alternative for patients with a high pretest probability of moderate-to-severe OSA and no significant comorbidities. HSAT devices are simpler than in-lab PSG, typically measuring airflow, respiratory effort, and oxygen saturation, and wearable and ring-based technologies have expanded consumer awareness (though consumer gadgets are screening aids, not diagnostic tests). Home tests are less expensive and more convenient but may underestimate severity and cannot diagnose central sleep apnea or other sleep disorders. The AASM recommends that negative or inconclusive HSAT results be followed by in-lab PSG.
CPAP Therapy: The Gold Standard
Continuous positive airway pressure (CPAP) is the first-line treatment for moderate-to-severe obstructive sleep apnea. A CPAP machine delivers a steady stream of pressurized air through a mask worn over the nose, mouth, or both, splinting the airway open and preventing collapse during sleep. When used consistently, CPAP eliminates apneas and hypopneas, normalizes oxygen levels, reduces daytime sleepiness, and can improve blood pressure and quality of life.
The challenge with CPAP is adherence. Studies consistently show that a substantial share of patients struggle with long-term CPAP compliance. Common barriers include mask discomfort, air leak, nasal congestion or dryness, claustrophobia, difficulty adjusting to sleeping with the mask, and noise. Modern CPAP machines are significantly quieter and more comfortable than earlier models, and features like heated humidification, auto-titrating pressure (APAP), and a wide variety of mask styles have improved tolerability.
Tips for CPAP success include working with your sleep specialist to find the right mask (nasal pillows, nasal mask, or full-face mask), using heated humidification, practicing wearing the mask while awake to desensitize, and using the ramp feature (which starts at a lower pressure and gradually increases). Most modern CPAP machines track usage data and can be monitored remotely by your sleep provider, allowing adjustments without an office visit. If CPAP is not working for you, tell your provider rather than quietly abandoning therapy – there are alternatives.
Alternative and Adjunct Treatments
For mild-to-moderate OSA, or for patients who cannot tolerate CPAP, oral appliance therapy is an effective alternative. A mandibular advancement device (MAD), custom-fitted by a dentist trained in sleep medicine, holds the lower jaw forward during sleep, keeping the airway open. The American Dental Association recognizes MADs as an appropriate treatment for OSA when fitted by a qualified provider. They are generally better tolerated than CPAP, though they may be less effective for severe OSA.
Surgical options include uvulopalatopharyngoplasty (UPPP), which removes excess tissue from the throat; maxillomandibular advancement (MMA), which moves the jaw forward to enlarge the airway; and hypoglossal-nerve stimulation (Inspire therapy), which uses an implanted device to stimulate the nerve controlling the tongue, preventing it from collapsing backward during sleep. Inspire therapy has shown good results in selected patients with moderate-to-severe OSA who cannot tolerate CPAP, and eligibility criteria have broadened over time; it is now covered by many insurance plans.
Positional therapy (avoiding sleeping on the back) can help patients whose apnea is predominantly positional. Weight loss significantly improves OSA severity – even a modest reduction in body weight can meaningfully lower the AHI, and bariatric surgery can resolve OSA in a significant proportion of people with severe obesity. Nasal treatments (surgery for a deviated septum, nasal corticosteroids) may improve CPAP tolerance or mild OSA. Understanding the costs of different treatment options – from CPAP machines to surgery – helps with decision-making.
Medication: A Newer Option for OSA With Obesity
In December 2024, the U.S. Food and Drug Administration approved the medication tirzepatide (brand name Zepbound) for moderate-to-severe obstructive sleep apnea in adults who also have obesity – the first prescription drug approved specifically to treat OSA. In clinical trials, this GLP-1/GIP-based medication, used alongside a reduced-calorie diet and increased activity, reduced the number of breathing events per hour in this population. This is a meaningful development, but it comes with important caveats: it is approved for a specific group (OSA plus obesity), it is not a substitute for a proper sleep evaluation, and whether it is appropriate for you – and whether it replaces or complements therapies like CPAP – is a decision for your clinician. Coverage, cost, and long-term outcomes are still evolving, so discuss the trade-offs with your provider rather than assuming a pill can replace established treatment.
Central Sleep Apnea Treatment
Central sleep apnea management differs from OSA because the problem is respiratory control rather than airway obstruction. The first step is treating the underlying cause – optimizing heart-failure management, reducing opioid doses when possible under medical supervision, or addressing other contributing conditions. CPAP can help some CSA patients, but adaptive servo-ventilation (ASV) – a sophisticated device that adjusts pressure breath-by-breath to stabilize breathing patterns – is more effective for many.
However, ASV is contraindicated in patients with CSA due to heart failure with reduced ejection fraction (below roughly 45%), as the SERVE-HF trial found increased mortality in this population. For these patients, other options include supplemental oxygen, phrenic-nerve stimulation (an implanted device that stimulates the diaphragm), and optimization of cardiac medications. CSA management is complex and should involve a sleep specialist, often in collaboration with a cardiologist.
Frequently Asked Questions
Can sleep apnea be cured?
It depends on the underlying cause. If excess weight is the primary driver, significant weight loss can resolve OSA in some patients. Surgical correction of anatomical obstructions can also be curative in select cases. However, for most patients, sleep apnea is a chronic condition that requires ongoing management. Even after weight loss, follow-up sleep testing is recommended to confirm resolution, as apnea can recur with weight regain.
Is snoring always a sign of sleep apnea?
No. Simple snoring – without breathing pauses, oxygen desaturations, or daytime symptoms – is common and not necessarily indicative of sleep apnea. However, loud, habitual snoring is a strong risk factor and should be evaluated, particularly if accompanied by witnessed apneas, excessive daytime sleepiness, or other symptoms. A sleep study is the only way to definitively distinguish benign snoring from sleep apnea.
How long does it take to feel better on CPAP?
Many patients notice improvement in daytime alertness within the first few days to weeks of consistent CPAP use. Optimal benefits – including blood-pressure improvement and full resolution of daytime sleepiness – may take several weeks to months. Some patients experience dramatic overnight improvement, while others require time to acclimate to the device before noticing benefits. Using CPAP for at least four hours per night is often cited as the minimum threshold associated with clinical benefit, though more is generally better.
Can children have sleep apnea?
Yes. Pediatric sleep apnea affects an estimated 1-5% of children, most commonly due to enlarged tonsils and adenoids. Symptoms in children may include snoring, restless sleep, bedwetting, mouth breathing, behavioral problems, and difficulty concentrating in school (sometimes mistaken for ADHD). Adenotonsillectomy is the first-line treatment for most children with OSA. Children with obesity, craniofacial abnormalities, or neuromuscular conditions may have persistent OSA requiring CPAP or other interventions.
Does sleeping position affect sleep apnea?
Yes. Many people have worse sleep apnea when sleeping on their back (supine position) because gravity pulls the tongue and soft tissues backward, narrowing the airway. This is called positional OSA. Sleeping on your side can reduce the number of breathing events in some patients. Positional-therapy devices – ranging from tennis balls sewn into the back of a shirt to wearable electronic devices that vibrate when you roll onto your back – can help maintain a side-sleeping position.
Is the new sleep apnea medication a replacement for CPAP?
Not necessarily. Tirzepatide (Zepbound) was approved in 2024 for moderate-to-severe OSA specifically in adults who also have obesity, and it is meant to be used with diet and exercise. It does not apply to everyone with sleep apnea, and it is not automatically a substitute for CPAP or other therapies. Whether it fits your situation – alone or alongside other treatments – is a conversation to have with your clinician after a proper evaluation.
Taking Sleep Seriously
If you snore loudly, wake unrefreshed, or feel excessively sleepy during the day, talk to your doctor about a sleep evaluation. If your bed partner has noticed that you stop breathing during sleep, do not dismiss it. Sleep apnea is not just a nuisance – it is a serious medical condition with cardiovascular, metabolic, and safety consequences that compound over years of untreated disease.
Getting evaluated is more straightforward than ever, and treatment options have never been more varied – from home sleep testing and CPAP to oral appliances, nerve stimulation, weight management, and, for a specific group, medication. CPAP remains the most effective treatment for moderate-to-severe OSA, but alternatives exist for those who struggle with it. The most important step is the first one – acknowledging the problem and getting tested. Your heart, brain, metabolism, and daily quality of life all depend on the quality of your sleep.
This article is for general education and is not medical advice. It cannot diagnose sleep apnea or recommend a specific treatment for you. Talk with a qualified clinician about testing and treatment, and treat any signs of a heart attack or stroke as a 911 emergency.
Sources
- American Academy of Sleep Medicine (AASM) – Sleep apnea overview; home sleep apnea testing guidance
- National Heart, Lung, and Blood Institute (NHLBI) – Sleep Apnea
- U.S. Food and Drug Administration (FDA) – Approval of Zepbound (tirzepatide) for moderate-to-severe obstructive sleep apnea in adults with obesity (December 2024)
- American Heart Association – Obstructive sleep apnea and cardiovascular disease
- American Dental Association (ADA) – Oral appliance therapy for sleep apnea
- MedlinePlus (U.S. National Library of Medicine) – Sleep Apnea